---
url: https://www.servicesaustralia.gov.au/severe-asthma
title: Severe asthma - Health professionals - Services AustraliaServices AustraliaServices Australia
scrapedAt: 2026-02-20T21:40:03.326Z
source: servicesaustralia.gov.au
---
# Severe asthma

The PBS subsidises biological medicines for patients with severe asthma.

## on this page

-   [Patient eligibility](#a1)
-   [Section 100 arrangements](#a2)
-   [Treatment specifics](#a3)
-   [Authority applications](#a4)
-   [More information](#a5)

## Patient eligibility

The Pharmaceutical Benefits Scheme (PBS) subsidises treatment with biological medicines under the _National Health Act 1953_, section 100 for patients with severe asthma.

Where the term biological medicine appears, it refers to benralizumab, dupilumab, mepolizumab and omalizumab.

Patients must be eligible for the [PBS](/pharmaceutical-benefits-scheme) and meet the relevant restriction criteria.

The [Schedule of Pharmaceutical Benefits](http://www.pbs.gov.au/pbs/home;jsessionid=jrrab7f28xtjycras12yiccu) on the PBS website outlines the restrictions for prescribing biological medicines.

## Section 100 arrangements

### benralizumab, dupilumab, mepolizumab and omalizumab

These items are only PBS-subsidised for non-admitted patients, day admitted patients, or patients on discharge who are attending either:

-   an approved private hospital
-   a public hospital.

These items aren’t PBS-subsidised for public hospital in-patients. You must include the hospital name and provider number on the authority application form.

## Treatment specifics

To be eligible for PBS-subsidised treatment with biological medicines, patients aged 12 years or older must be treated by one of the following:

-   a respiratory physician
-   a clinical immunologist
-   an allergist
-   a general physician with expertise in managing asthma.

Patients aged 6 to less than 12 years old must be treated by one of the following:

-   a paediatric respiratory physician
-   a clinical immunologist
-   an allergist.

They can also be treated by either of the following in consultation with a respiratory physician:

-   a paediatrician experienced in the management of patients with severe asthma
-   a general physician experienced in the management of patients with severe asthma.

## Authority applications

### Adolescent and adult patients (12 years or older)

#### Applying for initial treatment

Please note: You don’t need to complete this application in writing when you request [PBS authority online](/apply-for-pbs-authority?context=20).

Applications for initial authority approval to prescribe PBS-subsidised biological medicines to treat uncontrolled severe asthma can be made:

-   using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20#accordion1)
-   in writing and use [HPOS Form upload](/upload-forms-hpos?context=20)
-   in writing and mail to [PBS Complex Drugs Programs](/health-professionals-contact-information?context=20#complexdrugs).

All written applications must include:

-   details of the proposed prescription or prescriptions
-   the completed [severe asthma - adolescent and adult - initial or recommencement after 12 months break authority application form](/pb075?context=20)
-   relevant attachments.

You can also use this authority application form to recommence treatment in a new treatment cycle. The new cycle must follow a mandatory 12-month break where there was no response after 4 biological treatments.

#### Applying for change of treatment

Please note: You don’t need to complete this application in writing when you request [PBS authority online](/apply-for-pbs-authority?context=20).

Applications to change authority approval to prescribe PBS-subsidised biological medicines to treat uncontrolled severe asthma can be made:

-   using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20#accordion1)
-   in writing and use [HPOS Form upload](/upload-forms-hpos?context=20)
-   in writing and mail to [PBS Complex Drugs Programs](/health-professionals-contact-information?context=20#complexdrugs).

All written applications must include:

-   details of the proposed prescription or prescriptions
-   the completed [severe asthma - adolescent and adult - change authority application form](/pb285?context=20)
-   relevant attachments.

#### Applying for recommencement of treatment

Please note: You don’t need to complete this application in writing when you request [PBS authority online](/apply-for-pbs-authority?context=20).

Applications to recommence authority approval to prescribe PBS-subsidised biological medicines to treat uncontrolled severe asthma can be made:

-   using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20#accordion1)
-   in writing and use [HPOS Form upload](/upload-forms-hpos?context=20)
-   in writing and mail to [PBS Complex Drugs Programs](/health-professionals-contact-information?context=20#complexdrugs).

For patients recommencing treatment after a voluntary break in treatment where a demonstration of response was recorded prior to commencing the treatment break, apply under either:

-   the continuing treatment restriction where the patient is recommencing treatment with the same biological medicine approved for the most recent PBS-subsidised treatment
-   the initial 2 (change) treatment restriction where the patient is recommencing with a biological medicine other than the one approved for the most recent PBS-subsidised treatment.

For patients recommencing treatment after a mandatory 12-month treatment break after failing to demonstrate a response, apply under the initial treatment restriction.

All written applications must include:

-   details of the proposed prescription or prescriptions
-   the completed authority application form according to the relevant treatment restriction
-   relevant attachments.

#### Applying for continuing treatment excluding omalizumab

Please note: You’ll get an immediate assessment when you request [PBS authorities online](/apply-for-pbs-authority?context=20#accordion1).

Applications for continuing authority approval to prescribe PBS-subsidised biological medicines to treat uncontrolled severe asthma can be made in:

-   real time using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20#accordion1)
-   writing and use [HPOS Form upload](/upload-forms-hpos?context=20)
-   writing and mail to [PBS Complex Drugs Programs](/health-professionals-contact-information?context=20#complexdrugs).

All written applications must include:

-   details of the proposed prescription or prescriptions
-   the completed [severe asthma - adolescent and adult - continuing authority application form](/pb076?context=20)
-   relevant attachments.

#### Applying for continuing treatment with omalizumab

Applications for continuing authority approval to prescribe PBS-subsidised omalizumab to treat uncontrolled severe asthma can be made:

-   in real time using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20)
-   by calling the [PBS Complex Drugs Programs enquiry line](/health-professionals-contact-information?context=20#complexdrugs).

Application for continuing PBS-subsidised treatment with biosimilar brand of omalizumab is Authority Required (Streamlined). You don’t need authority approval from us for the listed quantities and repeats.

### Paediatric patients (aged 6 to less than 12 years)

#### Applying for initial treatment or recommencement of treatment after a break of at least 12 months

Please note: You don’t need to complete this application in writing when you request [PBS authority online](/apply-for-pbs-authority?context=20).

Applications for initial or recommencement authority approval to prescribe PBS-subsidised dupilumab or omalizumab to treat uncontrolled severe asthma or severe allergic asthma can be made:

-   using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20#accordion1)
-   in writing and use [HPOS Form upload](/upload-forms-hpos?context=20)
-   in writing and mail to [PBS Complex Drugs Programs](/health-professionals-contact-information?context=20#complexdrugs).

All written applications must include:

-   details of the proposed prescription or prescriptions
-   the completed [severe asthma paediatric - dupilumab or omalizumab - initial or recommencement authority application form](/pb188?context=20)
-   relevant attachments.

#### Applying for initial grandfather treatment

Please note: You don’t need to complete this application in writing when you request [PBS authority online](/apply-for-pbs-authority?context=20).

Applications for initial grandfather authority approval to prescribe PBS-subsidised dupilumab to treat uncontrolled severe asthma can be made:

-   using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20#accordion1)
-   in writing and use [HPOS Form upload](/upload-forms-hpos?context=20)
-   in writing and mail to [PBS Complex Drugs Programs](/health-professionals-contact-information?context=20#complexdrugs).

All written applications must include:

-   details of the proposed prescription or prescriptions
-   the completed [severe asthma paediatric - dupilumab - initial grandfather authority application form](/pb386?context=20)
-   relevant attachments.

#### Applying for change of treatment

Please note: You don’t need to complete this application in writing when you request [PBS authority online](/apply-for-pbs-authority?context=20).

Applications to change authority approval to prescribe PBS-subsidised dupilumab or omalizumab to treat uncontrolled severe asthma or severe allergic asthma can be made:

-   using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20)
-   in writing and use [HPOS form upload](/upload-forms-hpos?context=20)
-   in writing and mail to [PBS Complex Drugs Programs](/health-professionals-contact-information?context=20#complexdrugs).

All written applications must include:

-   details of the proposed prescription or prescriptions
-   the completed [severe asthma paediatric - change or continuing authority application form](/pb385?context=20)
-   relevant attachments.

#### Applying for continuing treatment with dupilumab

Please note: You’ll get an immediate assessment when you request [PBS authorities online](/apply-for-pbs-authority?context=20).

Applications for continuing authority approval to prescribe PBS-subsidised dupilumab to treat uncontrolled severe asthma can be made in:

-   real time using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20)
-   writing and use [HPOS form upload](/upload-forms-hpos?context=20)
-   writing and mail to [PBS Complex Drugs Programs](/health-professionals-contact-information?context=20#complexdrugs).

All written applications must include:

-   details of the proposed prescription or prescriptions
-   the completed [severe asthma paediatric - change or continuing authority application form](/pb385?context=20)
-   relevant attachments.

#### Applying for continuing treatment with omalizumab

Applications for continuing authority approval to prescribe PBS-subsidised omalizumab to treat uncontrolled severe allergic asthma can be made either:

-   in real time using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20)
-   by calling the [PBS Complex Drugs Programs enquiry line](/health-professionals-contact-information?context=20#complexdrugs).

Application for continuing PBS-subsidised treatment with biosimilar brand of omalizumab is Authority Required (Streamlined). You don’t need authority approval from us for the listed quantities and repeats.

## More information

Call the [PBS Complex Drugs Programs enquiry line](/health-professionals-contact-information?context=20#complexdrugs) for more information.

[

Severe asthma toxicity and severity descriptors

Toxicity criteria and severity descriptors for treatments required to be trialled before accessing PBS-subsidised biological medicines to treat severe asthma.


](/severe-asthma-toxicity-and-severity-descriptors?context=20)
